On April 29, the Co-Directors of Columbia University’s Naomi Berrie Diabetes Center will moderate the second in a series of panel discussions featuring some of the leading minds in the burgeoning fields of type 1 and type 2 diabetes research at Columbia University. The Berrie Center is the only comprehensive Diabetes Center in New York City and one of only a few in the world where the clinical and research programs are tightly coordinated.
“Scientific panels like this are a way to publically discuss current trends, discoveries and research programs that might typically only be accessible to the scientific community through scientific journals,” said Troy Finn, Chief Development Officer of the Naomi Berrie Diabetes Center—the nexus of the impressive, overall diabetes enterprise at the University, where more than 100 scientists and staff are focused on finding treatments and cures for diabetes.
Added Finn, “This is a way to break down any barriers between the scientific community—the people who are on the front lines of diabetes research—and people who have diabetes or are genuinely interested in finding cures.”
More than 100 people have registered to attend the April 29 panel, which will be a free-flowing, unscripted and spontaneous conversation between guests and scientists. One of the goals of the panel is to give the floor over to the audience and allow them to drive the agenda of the evening “We’re asking people to bring all of their questions,” said Finn.
The panel is being hosted at the University Club of New York by Mary Elizabeth Bunzel, Paul B. Healy and Alka K. Singh, friends of the Berrie Center who support diabetes research at Columbia. At the conclusion of the evening, guests will be invited to invest in the University's promising diabetes research programs.
Finn concluded, “The last research panel we facilitated was a fantastic experience. Our guests were so energized by the discussion and motivated to invest in the promising diabetes research that is happening at Columbia – funding that will drive the research that leads to cures.”